After more than five years, the debate rages on between Ophthalmology New Zealand (ONZ) and Southern Cross Health Society (SCHS) over funding for minimally invasive glaucoma surgery (MIGS) devices for glaucoma sufferers.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
- 11 print magazine issues per year
